Literature DB >> 28214589

Enhanced expression and purification of camelid single domain VHH antibodies from classical inclusion bodies.

Maristella Maggi1, Claudia Scotti2.   

Abstract

Single domain antibodies (sdAbs) are small antigen-binding domains derived from naturally occurring, heavy chain-only immunoglobulins isolated from camelid and sharks. They maintain the same binding capability of full-length IgGs but with improved thermal stability and permeability, which justifies their scientific, medical and industrial interest. Several described recombinant forms of sdAbs have been produced in different hosts and with different strategies. Here we present an optimized method for a time-saving, high yield production and extraction of a poly-histidine-tagged sdAb from Escherichia coli classical inclusion bodies. Protein expression and extraction were attempted using 4 different methods (e.g. autoinducing or IPTG-induced soluble expression, non-classical and classical inclusion bodies). The best method resulted to be expression in classical inclusion bodies and urea-mediated protein extraction which yielded 60-70 mg/l bacterial culture. The method we here describe can be of general interest for an enhanced and efficient heterologous expression of sdAbs for research and industrial purposes.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inclusion bodies; Protein expression; Purification optimization; Single domain antibody; VHH; sdAb

Mesh:

Substances:

Year:  2017        PMID: 28214589     DOI: 10.1016/j.pep.2017.02.007

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  4 in total

1.  Robust anti-SARS-CoV2 single domain antibodies cross neutralize multiple viruses.

Authors:  Sudhakar Singh; Surbhi Dahiya; Yuviana J Singh; Komal Beeton; Ayush Jain; Roman Sarkar; Abhishek Dubey; Azeez Tehseen; Sharvan Sehrawat
Journal:  iScience       Date:  2022-06-09

2.  Different strategies for expression and purification of the CT26-poly-neoepitopes vaccine in Escherichia coli.

Authors:  Zahra Movahed; Elham Sharif; Maryam Ahmadzadeh; Navid Nezafat; Hoda Jahandar; Elham Mohit
Journal:  Mol Biol Rep       Date:  2022-01-20       Impact factor: 2.316

3.  Data on enhanced expression and purification of camelid single domain antibodies from Escherichia coli classical inclusion bodies.

Authors:  Maristella Maggi; Claudia Scotti
Journal:  Data Brief       Date:  2017-03-31

Review 4.  Recombinant expression of nanobodies and nanobody-derived immunoreagents.

Authors:  Ario de Marco
Journal:  Protein Expr Purif       Date:  2020-04-11       Impact factor: 1.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.